Annals of Surgical Oncology, Vol 7, Issue 2 120-124, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging

S. Saha, D. Wiese, J. Badin, T. Beutler, D. Nora, B. K. Ganatra, D. Desai, S. Kaushal, M. Nagaraju, M. Arora and T. Singh
Department of Anatomy, Michigan State University, McLaren Regional Medical Center, Flint, USA. ssaha@aol.com

BACKGROUND: Sentinel lymph node (SLN) mapping for melanoma and breast cancer has greatly enhanced the identification of micrometastases in many patients, thereby upstaging a subset of these patients. The purpose of this study was to see if SLN mapping technique could be used to identify SLNs in colorectal cancer and to assess its impact on pathological staging and treatment. METHODS: At the time of surgery, 1 ml of Lymphazurin 1% was injected subserosally around the tumor without injecting into the lumen. The first to fourth blue nodes identified were considered the SLNs, which have the highest probability to contain metastases. A standard oncological resection of the bowel was then performed. Multilevel microsections of the SLNs, including a detailed pathological examination of the entire specimen, was performed. RESULTS: SLN was successfully identified in 85 (98.8%) of 86 patients. In 85 patients, there were 1,367 (16 per patient) lymph nodes examined, of which 140 (1.6 per patient) were identified as SLNs. In 53 (95%) of 56, of whom the SLNs were without metastases (negative), all other non-SLNs also were negative. In 29 (34% of 85) patients, SLNs were positive for metastases; in 14 of the 29 patients, other non-SLNs also were positive in addition to the SLNs. In the other 15 of the 29 patients (18% of 85 patients), SLNs were the only site of metastases, and all other non-SLNs were negative. In 7 patients (8.2% of 85 patients), micrometastases were identified only in 1 or 2 of the 10 sections of a single SLN. In five of seven patients, such micrometastases were detected by hematoxylin and eosin staining and immunohistochemistry; in the other two patients, it was detected only by immunohistochemistry. In patients with negative SLNs, the rate of occurrence of micrometastases in non-SLNs was 5 (0.4%) of 1,184 lymph nodes. CONCLUSIONS: SLN mapping can be performed easily in colorectal cancer patients, with an accuracy of more than 95%. The identification of submicroscopic lymph node metastases by this technique may have upstaged these patients (18%) from stage I/II to stage III disease, who may then benefit from further adjuvant chemotherapy.

This article has been cited by other articles:

				K. Koyanagi, A. J. Bilchik, S. Saha, R. R. Turner, D. Wiese, M. McCarter, P. Shen, L. Deacon, D. Elashoff, and D. S.B. Hoon Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial Clin. Cancer Res., November 15, 2008; 14(22): 7391 - 7396. [Abstract] [Full Text] [PDF]

				D. M. Iddings, E. A. Koda, S. S. Grewal, R. Parker, S. Saha, and A. Bilchik Association of Angiogenesis Markers With Lymph Node Metastasis in Early Colorectal Cancer Arch Surg, August 1, 2007; 142(8): 738 - 745. [Abstract] [Full Text] [PDF]

				R. J. de Haas, D. A. Wicherts, M. G. G. Hobbelink, I. H. M. B. Rinkes, M. E. I. Schipper, J.-A. van der Zee, and R. van Hillegersberg Sentinel Lymph Node Mapping in Colon Cancer: Current Status Ann. Surg. Oncol., March 1, 2007; 14(3): 1070 - 1080. [Abstract] [Full Text] [PDF]

				C. A. Quadros, A. Lopes, I. Araujo, F. Fahel, M. S. Bacellar, and C. S. Dias Retroperitoneal and Lateral Pelvic Lymphadenectomy Mapped by Lymphoscintigraphy and Blue Dye for Rectal Adenocarcinoma Staging: Preliminary Results Ann. Surg. Oncol., December 1, 2006; 13(12): 1617 - 1621. [Abstract] [Full Text] [PDF]

				S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309. [Abstract] [Full Text] [PDF]

				A. J. Bilchik, M. DiNome, S. Saha, R. R. Turner, D. Wiese, M. McCarter, D. S. B. Hoon, and D. L. Morton Prospective Multicenter Trial of Staging Adequacy in Colon Cancer: Preliminary Results Arch Surg, June 1, 2006; 141(6): 527 - 534. [Abstract] [Full Text] [PDF]

				M. Redston, C. C. Compton, B. W. Miedema, D. Niedzwiecki, J. M. Dowell, S. D. Jewell, J. M. Fleshman, J. Bem, R. J. Mayer, and M. M. Bertagnolli Analysis of Micrometastatic Disease in Sentinel Lymph Nodes From Resectable Colon Cancer: Results of Cancer and Leukemia Group B Trial 80001 J. Clin. Oncol., February 20, 2006; 24(6): 878 - 883. [Abstract] [Full Text] [PDF]

				R. P. Sticca Is There Clinical Value to Sentinel Lymph Node Sampling in Colon Cancer? J. Clin. Oncol., February 20, 2006; 24(6): 841 - 842. [Full Text] [PDF]

				C. Codignola, F. Zorzi, A. Zaniboni, S. Mutti, A. Rizzi, E. Padolecchia, and G. B. Morandi Is there any Role for Sentinel Node Mapping in Colorectal Cancer Staging? Personal Experience and Review of the Literature Jpn. J. Clin. Oncol., November 1, 2005; 35(11): 645 - 650. [Abstract] [Full Text] [PDF]

				J. H. Wong, D. S. Johnson, D. Hemmings, A. Hsu, T. Imai, and G. T. Tominaga Assessing the Quality of Colorectal Cancer Staging: Documenting the Process in Improving the Staging of Node-Negative Colorectal Cancer Arch Surg, September 1, 2005; 140(9): 881 - 887. [Abstract] [Full Text] [PDF]

				A. G. Dan, S. Saha, K. M. Monson, D. Wiese, E. Schochet, K. R. Barber, B. Ganatra, D. Desai, and S. Kaushal 1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal Tumors Arch Surg, November 1, 2004; 139(11): 1180 - 1184. [Abstract] [Full Text] [PDF]

				A. Zaniboni and R. Labianca Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann. Onc., September 1, 2004; 15(9): 1310 - 1318. [Abstract] [Full Text] [PDF]

				J. H. Wong, D. S. Johnson, T. Namiki, and P. Tauchi-Nishi Validation of Ex Vivo Lymphatic Mapping in Hematoxylin-Eosin Node-Negative Carcinoma of the Colon and Rectum Ann. Surg. Oncol., August 1, 2004; 11(8): 772 - 777. [Abstract] [Full Text] [PDF]

				S. Saha, A. G. Dan, A. J. Bilchik, Y. Kitagawa, E. Schochet, S. Choudhri, L. T. Saha, D. Wiese, D. Morton, and M. Kitajima Historical Review of Lymphatic Mapping in Gastrointestinal Malignancies Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 245S - 249S. [Abstract] [Full Text] [PDF]

				D F H Pheby, D F Levine, R W Pitcher, and N A Shepherd Lymph node harvests directly influence the staging of colorectal cancer: evidence from a regional audit J. Clin. Pathol., January 1, 2004; 57(1): 43 - 47. [Abstract] [Full Text] [PDF]

				J. Mendez, A. M. Wallace, C. K. Hoh, and D. R. Vera Detection of Gastric and Colonic Sentinel Nodes Through Endoscopic Administration of 99mTc-DTPA-Mannosyl-Dextran in Pigs J. Nucl. Med., October 1, 2003; 44(10): 1677 - 1681. [Abstract] [Full Text] [PDF]

				G Cserni Nodal staging of colorectal carcinomas and sentinel nodes J. Clin. Pathol., May 1, 2003; 56(5): 327 - 335. [Abstract] [Full Text] [PDF]

				J. W. Jakub, S. Pendas, and D. S. Reintgen Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies Oncologist, February 1, 2003; 8(1): 59 - 68. [Abstract] [Full Text] [PDF]

				R. J. Feezor, E. M. Copeland III, and S. N. Hochwald Significance of Micrometastases in Colorectal Cancer Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953. [Full Text] [PDF]

				A. J. Bilchik, D. T. Nora, S. Saha, R. Turner, D. Wiese, C. Kuo, X. Ye, D. L. Morton, and D. S. B. Hoon The Use of Molecular Profiling of Early Colorectal Cancer to Predict Micrometastases Arch Surg, December 1, 2002; 137(12): 1377 - 1383. [Abstract] [Full Text] [PDF]

				B. Taback, K. Hashimoto, C. T. Kuo, A. Chan, A. E. Giuliano, and D. S. B. Hoon Molecular Lymphatic Mapping of the Sentinel Lymph Node Am. J. Pathol., October 1, 2002; 161(4): 1153 - 1161. [Abstract] [Full Text] [PDF]

				J. C. Paramo, J. Summerall, R. Poppiti, and T. W. Mesko Validation of Sentinel Node Mapping in Patients With Colon Cancer Ann. Surg. Oncol., July 1, 2002; 9(6): 550 - 554. [Abstract] [Full Text] [PDF]

				G Cserni The influence of nodal size on the staging of colorectal carcinomas J. Clin. Pathol., May 1, 2002; 55(5): 386 - 390. [Abstract] [Full Text] [PDF]

				J. H. Wong, S. Steinemann, P. Tom, S. Morita, and P. Tauchi-Nishi Volume of Lymphatic Metastases Does Not Independently Influence Prognosis in Colorectal Cancer J. Clin. Oncol., March 15, 2002; 20(6): 1506 - 1511. [Abstract] [Full Text] [PDF]

				W. E. Taylor, J. H. Donohue, L. L. Gunderson, H. Nelson, D. M. Nagorney, R. M. Devine, M. G. Haddock, D. R. Larson, J. Rubin, and M. J. O'Connell The Mayo Clinic Experience With Multimodality Treatment of Locally Advanced or Recurrent Colon Cancer Ann. Surg. Oncol., March 1, 2002; 9(2): 177 - 185. [Abstract] [Full Text] [PDF]

				R. Rosenberg, A. Hoos, J. Mueller, P. Baier, D. Stricker, M. Werner, H. Nekarda, and J.-R. Siewert Prognostic Significance of Cytokeratin-20 Reverse Transcriptase Polymerase Chain Reaction in Lymph Nodes of Node-Negative Colorectal Cancer Patients J. Clin. Oncol., February 15, 2002; 20(4): 1049 - 1055. [Abstract] [Full Text] [PDF]

				P J Ell A revolution in surgical oncology: sentinel lymph node biopsy Imaging, September 1, 2001; 13(3): 197 - 205. [Abstract] [Full Text] [PDF]

				T. F. Wood, S. Saha, D. L. Morton, G. J. Tsioulias, D. Rangel, W. Hutchinson Jr., L. J. Foshag, and A. J. Bilchik Validation of Lymphatic Mapping in Colorectal Cancer: In Vivo, Ex Vivo, and Laparoscopic Techniques Ann. Surg. Oncol., March 1, 2001; 8(2): 150 - 157. [Abstract] [Full Text] [PDF]

				A. J. Bilchik, S. Saha, D. Wiese, J. A. Stonecypher, T. F. Wood, S. Sostrin, R. R. Turner, H.-J. Wang, D. L. Morton, and D. S.B. Hoon Molecular Staging of Early Colon Cancer on the Basis of Sentinel Node Analysis: A Multicenter Phase II Trial J. Clin. Oncol., February 15, 2001; 19(4): 1128 - 1136. [Abstract] [Full Text] [PDF]